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1. Introduction
strocytes are major cell types in brain with 
numerous important functions. In contrast 
to previous believes, they are not only 
supporting cells but also recent findings 
have shown their biological importance 
in physio- and pathophysiological condi-
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Introduction: Recent studies have shown that astrocytes play major roles in normal and 
disease condition of the central nervous system including multiple sclerosis (MS).  Molecular 
target therapy studies in MS have revealed that connexin-43 (Cx43) and Aquaporin-4 (AQP4) 
contents of astrocytes undergo expression alteration. Fluoxetine had some effects in MS patients 
unrelated to its known antidepressant effects. Some of fluoxetine effects were attributed to its 
capability of cAMP signaling pathway stimulation. This study aimed to investigate possible 
acute effects of  fluoxetine on  Cx43 and AQP4 expression in astrocyte.
Methods: Astrocytoma cells were treated for 24 hours with fluoxetine (10 and 20 μg/ml) with 
or without adenyl cyclase (AC) and protein kinase A (PKA) inhibition. Cx43 expression at 
both mRNA and protein levels and AQP4 expression at mRNA level were evaluated. 
Results: Acquired results showed that fluoxetine with and without AC and PKA inhibition 
resulted in Cx43 up-regulation both in mRNA and protein levels, whereas AQP4 expression 
have not changed. 
Discussion: In conclusion, data showed that fluoxetine alone and in the absence of serotonin 
acutely up-regulated Cx43 expression in astrocytes that can be assumed in molecular target 
therapy of MS patients. It seems that cAMP involvement in fluoxetine effects need more 
researches. 
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A
tions (He and Sun 2007). Multiple sclerosis is one of the 
diseases that based on recent findings astrocyte involve-
ment have highlighted in progression of this disease. 
Although oligodendrocytes are known as myelinating 
cell type, astrocytes provide essential roles in establish-
ing and maintaining a communication path within the 
inflamatory demyelinated lesions and so creating a fa-
vorable environment for remyelination (Keyser, Laureys 
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et al. 2010). These communication networks provide by 
some astrocyte elements including Cx43 and AQP4 (Ne-
dergaard, Ransom et al. 2003).  
Studies have shown that expression of Cx43 and AQP4 
altered in multiple sclerosis animal models and patients 
(Brand-Schieber, Beelitz et al. 2005; Li, Zhang et al. 
2009). 
Deletion of Cx43, the primary protein forming gap 
junction channels in astrocytes, has been shown that led 
to dysmyelinating Phenotype (Lutz, Zhao et al. 2009). 
In an Animal Model of Multiple Sclerosis, it was found 
that Cx43 is down-regulated in inflamed white matter of 
centeral nervous system (Brand-Schieber, Beelitz et al. 
2005). 
AQP4 is the most important member of the aquapo-
rin family in astrocytes and has key roles in maintaining 
water and ion homeostasis. It was suggested that AQP4 
may have other functions that is unrelated to its water 
transport role (Verkman 2009).
Possible involvement of AQP4 in CNS inflamma-
tory diseases has been suggested based on evidences 
that have demonstrated auto-antibodies existed against 
AQP4 in patients with neuromyelitis optica (NMO) 
(Graber1, Levy et al. 2008). Moreover, up-regulation 
of AQP4 in CNS of animal model of MS provided 
more support for the possible involvement of AQP4 in 
CNS inflammatory diseases (Miyamoto, Nagaosa et al. 
2009).    
In addition, correction of Cx43 and AQP4 expression 
alterations had relationship with re-myelination. In a 
guinea pig model of  experimental autoimmune en-
cephalomyelitis (EAE),  expression of Cx43 was almost 
absent in all demyelinated lesions, on the other hand, 
treated animals showed up-regulation of Cx43 in all re-
myelinating lesions (Roscoe, Messersmith et al. 2007). 
With regards to AQP4 expression and EAE, it was 
shown that AQP4 knockout mice had more attenuated 
EAE severity (Li, Zhang et al. 2009). 
Some previous researches have revealed that enhanc-
ing intracellular cAMP signalling pathways in astro-
cytes in patients with MS may reduces the severity 
of the disease (Keyser, Zeinstra et al. 2003; Mostert, 
Admiraal-Behloul et al. 2008). Further more, cAMP 
signaling pathway relationship with Cx43 and AQP4 
expressions have been shown (TenBroek, Lampe et al. 
2001; Kortenoeven, Trimpert et al. 2012). Fluoxetine, as 
a selective serotonin reuptake inhibitor (SSRI), widely 
used in depression (Rossi, Barraco et al. 2004), has been 
shown to elevate cAMP levels in astrocytes (Mostert, 
Admiraal-Behloul et al. 2008) and reduced the devel-
opment of focal inflammatory lesions (Keyser, Laureys 
et al. 2010). Kong et al reported that fluoxetine needs 
AQP4 to induce  antidepressive effect (Kong, Sha et al. 
2009).
Motivated by the potential effects of fluoxetine on 
biological pathways in astrocytes, we studied possible 
effects of fluoxetine on expression of Cx43 and AQP4 
in astrocytic cell lines through cAMP and its newly de-
scribed downstream Epac (exchange protein directly ac-
tivated by cAMP) (Kawasaki, Springett et al. 1998). As a 
model system, we used the human astrocytoma cell lines 
1321N1 and U87MG, which have been shown to be use-
ful cell lines to investigate signal transduction (Harden, 
Cotton et al. 1980 ). 
2.  Methods 
2.1. Materials
All drugs in this study including Fluoxetine hydro-
chloride, (F132), adenyl cyclase inhibitor, SQ 22,536 (S 
153), PKA specific inhibitor (H-89) (B1427) were pur-
chased from Sigma-Aldrich (USA). Qiazol and reverse 
transcriptase were purchased from Qiagen and vivantis 
respectively.
2.2. Cell Culture 
The human astrocytoma cell lines including 1321N1 
and U87MG were obtained from the Stem Cell Tech-
nology Research Center, (Tehran, Iran) and were grown 
in DMEM containing 10% FBS, incubated at 5% CO2 
and 37˚C temperature. Cells were plated in six-well 
plates for RNA extraction analysis. Treatment was done 
when the cell confluency reach to 70-80% following re-
placement of medium with DMEM containing 1% FBS. 
2.3. Real-time Reverse Transcription-Polymerase 
Chain Reaction Assay
Relative expressions of Cx43 and AQP4 genes were 
measured on treated and controls cells 24 hours after 
treatment. Total cellular mRNA was extracted using the 
Qiazol  (Qiagen) then used for cDNA synthesis by re-
verse transcriptase (vivantis Cat No: RTPL12). HPRT1 
used as the housekeeping gene.  The primers were used 
in the reactions had the following sequences:
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 Cx43 forward: 5′- GAT GAG GAA GGA AGA GAA 
G -3′,
 Cx43 reverse: 5′- CGC TAG CTT GCT TGT TGT 
AA -3′, 
AQP4 forward: 5′-  CTG ATG TCA CTG GCT CAA 
TAG-3′, 
AQP4 reverse :5′- ACC CAA TAT ATC CAA TGG-3′, 
Epac forward: 5′- CGA  TTC  ACT  GAC  TCC  CTT 
AC -3′,
 Epac reverse: 5′- CTT  CCA  AAT  GTG  TGA  TAG 
ATT  AG -3′, 
HPRT1  forward: 5′- CCT GGC GTC GTG ATT AGT 
G -3′, 
HPRT1 reverse: 5′- TCA GTC CTG TCC ATA ATT 
AGT CC -3′. 
Gene expression levels were quantified by Rotor Gene 
6000 (Corbett, Concorde, NSW, Australia). The relative 
expression ratio of genes was calculated using the rela-
tive expression software tool (REST). 
2.3. Western Blot Analysis
Immunoblotting assay were performed using corre-
spond antibodies for detection of Cx43 and EPAC. Total 
cell lysates were collected by using ice-cold PBS and 
homogenization in cold lysis buffer (RIPA buffer). ly-
sate clarified by centrifugation at 12,000 rpm for 10 min, 
supernatant transferred to a new tube. Protein content 
was measured using the BCA protein kit (Pierce). Equal 
amount of protein (25μg) in each sample was loaded 
to 12.5% standard SDS-PAGE. By using a wet system 
(Bio-Rad) the proteins were transferred to PVDF mem-
branes. After blocking, membranes were incubated over 
night with primary antibodies (1/1000), washed three 
times with TBST 20 (0.5%) incubated with secondary 
antibody (1/5000) for 1 hour at room temperature. Af-
ter three washes, detection was performed by applying 
Pierce ECL Plus Western Blotting Substrate (#32134), 
emanating chemiluminescence from the membrane for 
manual x-ray film development. Protein levels were nor-
malized to β-actin. 
3. Results 
3.1. EPAC expression in Cell Lines
To evaluate possible effect of fluoxetine on expres-
sion of EPAC in U87MG and 1321N1 cell lines, we 
performed Real- time PCR analysis on cDNA obtained 
from these cells using specific primers for detection of 
EPAC. We found that fluoxetine did not change the ex-
pression of EPAC mRNA in both cell lines (Fig. 1).
Figure 1. Relative expression of Epac in 1321N1 (Fig. 1A) and U87MG (Fig. 1B) cell lines in un-treated (C) and 
treated cells with 10 μg/ml fluoxetine (F) HPRT1 was used as internal control.
 * P<0.05; ** P<0.01; PTZ, Pentylenetetrazol; Ctrl, Control; SB, SB334867; ORX, Orexin-A; Lido., lidocaine
3.2. Effect of fluoxetine on Cx43 expression
Treatment of cells with 10 and 20 μg/ml of fluoxetine 
for 24 hours resulted in up-regulation of Cx43 both in 
mRNA (Fig. 2) and protein (Fig. 3) levels. These effects 
were not dose dependent. As our data revealed that in 
40 μg/ml of fluoxetine complete cell death occurred. To 
evaluate the specificity of this finding cells pretreated 
for 45 minutes with SQ 22,536 (20 μg/ml) as an AC 
inhibitor, and H-89 (10 μg/ml), as PKA inhibitor, these 
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pretreatments declined the fluoxetine effects on Cx43 
expression, but not returned it to basal level. Suggest-
ing that up-regulation of Cx43 seen in the presence of 
fluoxetine may have gone partially via cAMP-Epac and 
without PKA pathway.
3.3. Effect of Fluoxetine on AQP4 Expression
We reported in our previous study (not published yet) 
that AQP4 was not expressed in 1321N1 cells using RT-
Figure 2. Fluoxetine effects on Cx43 mRNA expression with 
and without cAMP-PKA signaling pathway. 1321N1 cells 
treated with F (Fluoxetine), SF (AC inhibitor+ Fluoxetine) 
and F+H89 (Fluoxetine + PKA inhibitor) for 24 hours and 
changes in transcript amount expression were determined 
by real-time qPCR. It revealed an up-regulation of Cx43 in all 
of groups (*p < 0.01 compared to untreated controls).
Figure 3. Expression of Cx43 protein in the 1321N1 cells. 
Cx43 protein levels were normalized to that of β-actin pro-
tein. Data are expressed as means ± S.E.M. Each immunob-
lotting was performed in duplicate to increase the reliability 
of the measurements. Lower Panels show representative im-
munoblots of Cx43 (43 kDa). C (un-treated), F (
Figure 4. Fluoxetine effects on AQP4 mRNA expression with 
and without cAMP-PKA signaling pathway. U87MG cells 
treated with F (Fluoxetine), SF (AC inhibitor+ Fluoxetine) 
and F+H89 (Fluoxetine + PKA inhibitor) for 24 hours and 
changes in transcript amount expression were determined 
by real-time qPCR. There were no significant differences in 
treated groups in compared to untreated controls.    
PCR and real time PCR. So we used U87MG glioma 
cells to study fluoxetine possible effect on AQP4 ex-
pression in this cell line. In U87MG cells, although 24 
hours treatment with fluoxetine (10 and 20 μg/ml) de-
creased AQP4 expression, but this effect was not signifi-
cant. Pretreatment of cells with AC inhibitor and PKA 
inhibitor had no effect on AQP4 expression level (Fig. 
4). These data suggested that expression of AQP4 in this 
cell line have other regulatory pathway.
4. Discussion 
The roles of astrocytes in CNS disorders are under in-
tense researches.  Alteration of astrocyte roles as loss of 
normal functions or the gain of abnormal functions may 
involve in disease initiation and progression, such as 
multiple sclerosis. Consistent with this idea recent find-
ings have demonstrated that Cx43 and AQP4 contents of 
astrocytes are changed in MS animal models or patients 
(Brand-Schieber, Beelitz et al. 2005; Miyamoto, Nagao-
sa et al. 2009). Besides the new finding about molecu-
lar mechanisms underling MS pathophysiology, new 
possible molecular targeted therapy has both clinical 
and experimental interest. Some reported studies have 
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demonstrated that fluoxetine could reduce formation of 
new enhancing lesions and had neuroprotective effects 
against axonal degeneration (Mostert, Admiraal-Behloul 
et al. 2008). Since fluoxetine has been shown to have 
relationship with the cAMP signaling pathway and have 
regulatory effects on Cx43 and AQP4 (Darrow, Fast et 
al. 1996; Kortenoeven, Trimpert et al. 2012), this study 
aimed to investigate possible fluoxetine effects on Cx43 
and AQP4 expression through cAMP-Epac pathway in 
astrocyte. We showed that 24 hours treatment of astro-
cytoma cells with fluoxetine resulted in up-regulation of 
Cx43 both in mRNA and protein levels. Investigation of 
the signaling pathway demonstrated that inhibition of 
cAMP production by AC inhibitor decline the fluoxetine 
effects on Cx43 expression, but not returns it to basal 
level. This can be attributed to partial effect of cAMP in 
total effect of fluoxetine on Cx43 expression. We have 
seen the same effect of PKA inhibitor on Cx43 level.
Our results are in line with previous study that showed 
Cx43 protein expression was significantly increased fol-
lowing treatment with fluoxetine (Fatemi, Folsom et al. 
2008). In this study, we want to investigate acute effect 
of fluoxetine in the absence of serotonin. Acute effect 
of fluoxetine on MAP kinase pathway activation in cul-
tured astrocytes has been showed (Mercier, Lennon et 
al. 2004).  Our data showed that pre-inhibition of AC 
and PKA decreased fluoxetine effects on Cx43 expres-
sion but this change was not significant. Although previ-
ous studies have reported that antidepressant treatment 
resulted in activation of AC and increased cAMP activity 
(Donati, Thukral et al. 2001), but our results have not 
confirmed AC and cAMP involvement in fluoxetine ef-
fects. We think that dosage and duration of treatment 
have role in this discrepancy observed in our study. 
With regards to AQP4 expression, fluoxetine had no 
significant effect. we used U87MG cell, which have 
higher glioma grade (Stiborová, Rupertová et al. 2011). 
So ineffectiveness of fluoxetine in alteration of AQP4 
expression may attribute to higher glioma grade of 
U87MG.  
In conclusion, we showed that 24 hours treatment with 
fluoxetine that can be assumed as acute treatment in-
creased Cx43 expression. Our data suggested that some 
fluoxetine effects can be attributed to its acute effects on 
Cx43 expression. So in MS patients that commonly have 
depression and based on researches have down-regulat-
ed level of Cx43, fluoxetine as an antidepressant with 
capability of crossing the blood-brain-barrier can have 
dual benefit effects.
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